approved egg-derived TIV

BIOLOGICAL2 trials

Sponsors

UMN Pharma Inc.

Conditions

InfluenzaVaccine

Phase 3

Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine

CompletedNCT01767896

UMN Pharma Inc.Influenza

Start: 2012-10-31End: 2013-03-31Updated: 2017-09-29

Study of ASP7374, Cell-culture-derived Influenza Vaccine

CompletedNCT01961947

UMN Pharma Inc.Influenza, Vaccine

Start: 2013-10-31End: 2013-11-30Updated: 2017-09-29